/
Liquidia Corporation
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
Mentions
3 mentions · latest on 5 Oct 2026
See which tracked investors hold Liquidia Corporation →Ownership and position changes on OwnershipTrace
| The Monday Morning Briefing: AI Drives Everything, Yet ROI on Massive Capex Remains Uncertain | - | 5 Oct 2026 | |
| Q1 2026 Investor Letter | - | 30 Apr 2026 (Q1 2026) | |
| The StonkstackBlog | A Year of Discipline: +27.7% | - | 16 Jan 2026 |